newsfilter
← Latest News
PR Newswire·

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medications to address...